AGIC Capital is a European-Asian private equity partnership focused on investment opportunities in the European mid-market. Founded in 2015, the firm aims at fostering sustainable growth by promoting its portfolio companies in Asia. The company presently manages equity commitments of over $2.2 billion across two funds. AGIC has offices in Munich, London, Hong Kong Shanghai, and Beijing and has around 25 employees. AGIC focuses on investments that significantly increase industrial productivity and efficiency, enable new applications and manufacturing methods, and drive innovation for industrial products and solutions. The firm focuses on investment opportunities in the following two industry sectors: (1) industrial technologies (2) medical technologies and life science. AGIC’s investment strategy is to support leading European small and medium companies that are seeking to expand into Asia by providing them with growth equity and access to the leading customers across China, Japan, S. Korea and India and South-East Asia. Through its local knowledge and strong relationships, AGIC helps companies to navigate the challenges presented by globalization and to capture the rich cross-fertilization of opportunities across Western and Asian markets. The fund supports its portfolio companies in the execution of their buy-and-build strategies, organic growth initiatives, and operating improvements. AGIC believes strongly in the concept of investing with a business purpose and working together with the top management of its companies.